An Randomized Control Trial Comparing Two Drug Combinations for Pain Management After Third Molars Surgery

NCT ID: NCT04874675

Last Updated: 2023-01-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

SUSPENDED

Clinical Phase

NA

Total Enrollment

78 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-31

Study Completion Date

2024-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Randomised control clinical trial to compare which combination of analgesics in effective in pain management after third molar extraction of wisdom teeth. The study will assess post operative pain after third molar extraction of two groups of study participants who will be given one of the two combinations of Diclofenac/ acetaminophen/codeine and ibuprofen/acetaminophen/codeine .

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Double blind randomized control clinical trial to compare the level of pain relief that occurs after third molar extraction done under local anaesthesia at the maxillofacial center, Harare, Zimbabwe. The participants will be randomized into two arms upon fitting the inclusion criteria.The pharmacist will be in charge of randomization and will randomise the participants upon giving them the medications. One group will receive combination of diclofenac/acetaminophen/codeine and the other group will receive ibuprofen/acetaminophen/codeine as post extraction analgesia.The dosages of the medications will be Diclofenac 50mg, ibuprofen 400mg, acetaminophen 500mg and codeine 15mg respectively. Questionnaires will be given to the patient to complete after discharge from the surgery and other parts of the questionnaire will be completed on review after 7 days. A record will be done of the postoperative pain experience (using visual analogue scale), use of rescue medication and details pertaining to impacted tooth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Impacted Third Molar Tooth PAIN

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Diclofenac /Acetaminophen/Codeine

routine pain medication used in post extraction pain management

Group Type ACTIVE_COMPARATOR

diclofenac / acetaminophen /codeine

Intervention Type DRUG

routine pain medication used post extraction of third molars

Ibuprofen/Acetaminophen/codeine

routine pain medication used in post extraction pain management

Group Type ACTIVE_COMPARATOR

ibuprofen/acetaminophen/codeine

Intervention Type DRUG

routine pain medication used post extraction of third molars

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

diclofenac / acetaminophen /codeine

routine pain medication used post extraction of third molars

Intervention Type DRUG

ibuprofen/acetaminophen/codeine

routine pain medication used post extraction of third molars

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

diclofenac/paracetamol/codeine phosphate ibuprofen/paracetamol/codeine phosphate

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients older than 18 years of age
* patients undergoing third molar extractions
* patients with or willing to get orthopantomogram for assessment of impacted third molars

Exclusion Criteria

* patients younger than 18 years
* patients not willing to consent to the study
* patients with associated co-morbidities
* patients not willing to undergo radiological evaluation
* patients allergic to medications used in the study
* pregnant patients
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

UZ-CHS-PERFECT

UNKNOWN

Sponsor Role collaborator

University of Zimbabwe

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Silas Bere

Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dr Silas bere

Harare, , Zimbabwe

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Zimbabwe

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UZCHS PERFECT THIRD MOLAR

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.